Janice Tiao is a Dermatology physician affiliated with Harvard University. OpenAlex indexes 16 publications with 346 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 Staniford St Ste 200
Boston, MA 021142543
Telephone
617-726-2914Provider last certified this registry record 4 Jul 2020.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Amgen Inc.Program year20251 payment
- AbbVie Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
24.3%Corticosteroid22%Triamcinolone Acetonide87%Fluocinolone Acetonide13%Part D<11 patientsAllylamine Antifungal2.2%Terbinafine Hcl100%Part D≥12 patientsAnti-infectives
22.2%Azole Antifungal13.5%Ketoconazole100%Part D≥52 patientsNitroimidazole Antimicrobial3.7%Metronidazole100%Part D≥15 patients+ 2 more classes in this area
Cancer & immunology
21.7%Nucleoside Metabolic Inhibitor7.7%Fluorouracil100%Part D≥48 patientsCalcineurin inhibitor5.2%Tacrolimus100%Part D≥23 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A retrospective study of adult patients with Parry–Romberg syndrome
Clinical and Experimental Dermatology
2024 - PB0051 Persistent Elevation of ɣ’ Fibrinogen in Acute and Convalescent COVID-19
Research and Practice in Thrombosis and Haemostasis
2023 - A Retrospective Study of Calcinosis Cutis in Patients With Systemic Lupus Erythematosus.
PubMed
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”